APA (7th ed.) Citation

Mavratzas, A., & Marmé, F. (2020). Alpelisib in the treatment of metastatic HR+ breast cancer with PIK3CA mutations. Future oncology, 17(1), . https://doi.org/10.2217/fon-2020-0464

Chicago Style (17th ed.) Citation

Mavratzas, Athanasios, and Frederik Marmé. "Alpelisib in the Treatment of Metastatic HR+ Breast Cancer with PIK3CA Mutations." Future Oncology 17, no. 1 (2020). https://doi.org/10.2217/fon-2020-0464.

MLA (9th ed.) Citation

Mavratzas, Athanasios, and Frederik Marmé. "Alpelisib in the Treatment of Metastatic HR+ Breast Cancer with PIK3CA Mutations." Future Oncology, vol. 17, no. 1, 2020, https://doi.org/10.2217/fon-2020-0464.